First co-infection of malaria and hepatitis E diagnosed in Sri Lanka
dc.contributor.author | Senarathne, S. | |
dc.contributor.author | Rajapakse, S. | |
dc.contributor.author | de Silva, H.J. | |
dc.contributor.author | Seneviratne, S. | |
dc.contributor.author | Chulasiri, P. | |
dc.contributor.author | Fernando, D. | |
dc.date.accessioned | 2023-10-25T07:07:20Z | |
dc.date.available | 2023-10-25T07:07:20Z | |
dc.date.issued | 2023 | |
dc.description | Poster Presentation Abstract (PP 049), 136th Anniversary International Medical Congress, Sri Lanka Medical Association, 25th-28th July 2023, Colombo, Sri Lanka | en_US |
dc.description.abstract | INTRODUCTION: Imported malaria cases continue to be reported in Sri Lanka. Similarly, hepatitis E is also considered a travel associated imported disease in Sri Lanka. This is a report of the first co-infection of malaria and hepatitis E in Sri Lanka. OBJECTIVES: A 21-year-old European who visited Sri Lanka after a 2 months stay in India, was admitted to hospital with fever, vomiting, abdominal pain, and dark-coloured urine on the 4th day after his arrival. On examination, he had splenomegaly but no hepatomegaly. He had thrombocytopaenia; 89% neutrophils; 9% lymphocytes; elevated liver enzymes and hyperbilirubinaemia. Urine was positive for bile pigment. METHODS: Considering his travel history to India, he was tested for malaria. The rapid diagnostic test became positive for Plasmodium falciparum while microscopy showed P. falciparum ring stages with a parasite density of 120/μl. He was treated as for uncomplicated P. falciparum malaria with oral Artemisinin-based Combination Therapy. The patient became fever-free and blood smears became negative after 13 hours following 2 doses of antimalarials. RESULTS: However, his liver functions were further deranged with apparent jaundice (ALT: 250 U/L; AST: 175 U/L; ALP: 130 U/L; GGT: 179 U/L; total bilirubin: 10.65 mg/dL; direct bilirubin: 8.08 mg/dL; indirect bilirubin: 2.57 mg/dL). Further blood tests detected hepatitis E-specific IgM antibodies. He was treated with oral ursodiol but no specific antiviral was given. Following the completion of antimalarials, he was discharged from the hospital upon clinical recovery. CONCLUSION: Clinicians should be vigilant on travel-associated co-infections in patients who are diagnosed with imported malaria. | en_US |
dc.identifier.citation | Sri Lanka Medical Association, 136th Anniversary International Medical Congress. 2023; 68 (Supplement S):S101 | en_US |
dc.identifier.issn | 0009-0875 | |
dc.identifier.uri | http://repository.kln.ac.lk/handle/123456789/26788 | |
dc.language.iso | en | en_US |
dc.publisher | Sri Lanka Medical Association | en_US |
dc.subject | malaria | en_US |
dc.subject | hepatitis E | en_US |
dc.subject | co-infections | en_US |
dc.title | First co-infection of malaria and hepatitis E diagnosed in Sri Lanka | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- Abstract-book-2023-FINAL-VERSION-2.0-101.pdf
- Size:
- 519.17 KB
- Format:
- Adobe Portable Document Format
- Description:
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: